Blog · Industry
Explore commercial, operational and financial data for your pharmaceutical business. Use dashboards and an AI analyst to prepare reports based on your products, territories and approved reporting data.
Supply chain analytics in the pharmaceutical industry compares batch inventory, expiration exposure, and delivery performance by product and site. Follow a worked inventory reconciliation that keeps restricted stock and overlapping risk categories visible.
Oct 23, 20266 min readChoose pharmaceutical ratios for product margin, research spending and working capital. A worked US company example connects gross-to-net deductions, operating costs and inventory days without inventing an industry target.
Oct 11, 20266 min readPharmaceutical sales analytics compares commercial sales across territories, products, accounts and channels. Build a net-sales reconciliation from aggregated exports, calculate the movement and check what the result can support.
Oct 11, 20265 min readGroup pharmaceutical business accounts by approved channel attributes, then compare sales and commercial coverage. This guide works through an account export, spreadsheet formulas, and the checks that keep the groups consistent.
Oct 3, 20265 min readCalculate the cash conversion cycle for a pharmaceutical business from inventory, receivables, and payables exports. Separate inventory stages, distributor balances, and supplier timing, then reconcile product-line results before comparing periods.
Sep 21, 20265 min readPharmaceutical demand forecasting needs separate views of commercial forecasts, channel orders, shipments, and inventory approaching its selling cutoff. Use a worked supply reconciliation and lot-level expiry exposure check with spreadsheet formulas.
Sep 18, 20265 min readHow to choose analytics software for Pharma: the questions, the data, ten vendor questions and the traps.
Sep 1, 20264 min readThe complete reach and frequency calculation on ten pharma target accounts over one cycle, small enough to check by hand: each account's dated access status, the calls logged, reach and frequency over all accounts against reach and frequency among accounts that can prescribe, the calls spent on blocked accounts, the open-access accounts with no call, the account whose access changed mid-cycle, and the assertion that targets equal open plus restricted plus blocked plus unknown, so a reader can reproduce every figure and then run it on their own call log and access file.
Aug 19, 20263 min readPharmaceutical marketing analytics compares campaign costs, reach, and defined engagement across channels and territories. Work from approved aggregate exports, reconcile the audience and cost totals, and separate descriptive campaign results from prescribing or clinical claims.
Aug 11, 20266 min readThe ten commercial KPIs a pharmaceutical sales organization should run on, each with its formula, the export it comes from and what it tells you: reach and frequency among accounts that can prescribe, calls on blocked accounts, access-weighted territory potential, pull-through after a formulary win, call plan attainment by plan version, sample to prescription relationship, target list currency, new prescriber activation, share within accessible accounts, and off-plan call rate. Also the three measures most teams miss, the figures to drop, the identities, and who owns what.
Aug 10, 20264 min readHow a pharmaceutical commercial team redraws territories from access-weighted potential rather than raw prescriber counts: each account's category volume times its access status, summed per candidate territory, the balance across territories, the accounts moved and the continuity of rep relationships, the calls released from blocked accounts, and the identity that the territories' weighted potential sums to the region's.
Aug 2, 20262 min readThe ten questions a pharmaceutical commercial head puts to the field and market access teams, what is reach and frequency among accounts that can prescribe, which calls went to blocked accounts, did the formulary win pull through, which territories are balanced on writable potential, which samples moved anything, which accounts have open access and no call, what did the cycle plan say against what happened, where did access change this month, which reps are off plan, and what changed, each with the table from the call log, the access file and the prescription data, and the answer to send back.
Jul 31, 20263 min readHow a pharmaceutical commercial team relates sample drops to prescription change per account and per territory, from the sample log and prescription data: the account's own baseline, the change in the weeks after sampling against accounts of the same tier not sampled, the territories where sampling moves nothing, and the honest wording that keeps a correlation from being reported as a cause.
Jul 23, 20262 min readA pharma dashboard connects commercial sales results with account coverage and product mix. This guide works through the figures, the source files, the reconciliation checks and the decisions each view supports.
Jul 19, 20265 min readHow a pharmaceutical field force computes reach and frequency per rep, territory and prescriber tier from the CRM call export and the call plan: the definitions, the roll-up that reconciles to the plan, a worked cycle, and the four ways the number is usually wrong.
Jul 18, 20264 min readHow a pharmaceutical commercial team measures whether a formulary or payer win turned into prescriptions, from the access file, the prescription data and the call log: the accounts whose access opened on a date, their prescriptions before and after against accounts whose access did not change, the calls made to them in the weeks after the win, the territories where access opened and nobody called, and the honest statement of what the difference is and is not.
Jul 17, 20262 min readWhy reach and frequency numbers drift when the call plan changes mid-cycle or calls are logged against prescribers who are not on it, how to keep plan versions with dates so every call is measured against the plan in force, and how to report off-plan calls as their own line rather than losing them.
Jul 12, 20263 min readHow a pharmaceutical commercial team carries formulary and access status on every account so that reach, frequency and share are computed among the accounts where the product can actually be prescribed, the two lists that fall out, calls on blocked accounts and uncalled accounts with open access, and the dated status that makes a quarter's numbers comparable to the last.
Jul 2, 20262 min readPharmaceuticals analytics for your business.
See the page